Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis (original) (raw)

Abstract

TMEM106B has recently been identified as a genetic risk factor for frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). Amyotrophic lateral sclerosis (ALS), like FTLD-TDP, is characterized by pathological TDP-43 inclusions. We therefore investigated whether FTLD-TDP-associated risk genotypes at TMEM106B (1) contribute to risk of developing ALS or (2) modify the clinical presentation in ALS. Detailed clinical and pathological information from 61 postmortem ALS patients was collected by database query, retrospective chart review, and histopathological slide review. DNA from these patients, as well as 24 additional ALS patients, was genotyped for three TMEM106B single nucleotide polymorphisms known to confer increased risk of FTLD-TDP. Associations between TMEM106B genotype and ALS were investigated by comparing TMEM106B genotypes in ALS patients (n = 85) and normal controls (n = 553), and associations between TMEM106B genotype and clinical and pathologic features were explored using linear regression. Multivariate linear models were used to evaluate the contributions of TMEM106B genotype and TDP-43 pathology to cognitive performance in ALS as measured by a phonemic verbal fluency test. We found that TMEM106B genotypes did not differ between ALS patients and normal controls. However, protective alleles at TMEM106B were significantly associated with preserved cognition in ALS patients, with the strongest association seen under a major-allele-dominant genetic model. While lower TDP-43 pathology scores and protective alleles at TMEM106B both correlated with better cognitive scores, these factors were not correlated with each other and demonstrated independent effects. These findings implicate the FTLD-TDP risk gene TMEM106B in the development of cognitive impairment in ALS.

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

1. Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611
   Article CAS PubMed Google Scholar
2. Benajiba L, Le Ber I, Camuzat A et al (2009) TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65:470–473
   Article CAS PubMed Google Scholar
3. Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–278 discussion 278–284
   Article CAS PubMed Google Scholar
4. Brandmeir NJ, Geser F, Kwong LK et al (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123–131
   Article PubMed Google Scholar
5. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299
   Article CAS PubMed Google Scholar
6. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21
   Article CAS PubMed Google Scholar
7. Chen-Plotkin AS, Lee VM, Trojanowski JQ (2010) TAR DNA-binding protein 43 in neurodegenerative disease_._ Nat Rev Neurol 6:211–220
   Google Scholar
8. Chio A, Schymick JC, Restagno G et al (2009) A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 18:1524–1532
   Article CAS PubMed Google Scholar
9. Cruts M, Van Broeckhoven C (2008) Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet 24:186–194
   Article CAS PubMed Google Scholar
10. Dunckley T, Huentelman MJ, Craig DW et al (2007) Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357:775–788
    Article CAS PubMed Google Scholar
11. Geser F, Brandmeir NJ, Kwong LK et al (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65:636–641
    Article PubMed Google Scholar
12. Geser F, Martinez-Lage M, Robinson J et al (2009) Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 66:180–189
    Article PubMed Google Scholar
13. Gitcho MA, Baloh RH, Chakraverty S et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538
    Article CAS PubMed Google Scholar
14. Hodges JR, Davies RR, Xuereb JH et al (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56:399–406
    Article PubMed Google Scholar
15. Kabashi E, Valdmanis PN, Dion P et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574
    Article CAS PubMed Google Scholar
16. Lezak M (1983) Neuropsychological assessment. Oxford University Press, New York
    Google Scholar
17. Libon DJ, Massimo L, Moore P et al (2007) Screening for frontotemporal dementias and Alzheimer’s disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis. Dement Geriatr Cogn Disord 24:441–447
    Article PubMed Google Scholar
18. Lomen-Hoerth C, Murphy J, Langmore S et al (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094–1097
    CAS PubMed Google Scholar
19. Mackenzie IR, Neumann M, Bigio EH et al (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117:15–18
    Article PubMed Google Scholar
20. Murphy JM, Henry RG, Langmore S et al (2007) Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 64:530–534
    Article PubMed Google Scholar
21. Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554
    CAS PubMed Google Scholar
22. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133
    Article CAS PubMed Google Scholar
23. Pesiridis GS, Lee VM-Y, Trojanowski JQ (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 18(R2):R156–R162
    Article CAS PubMed Google Scholar
24. Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6:994–1003
    Article CAS PubMed Google Scholar
25. Sreedharan J, Blair IP, Tripathi VB et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672
    Article CAS PubMed Google Scholar
26. Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131–146
    Article PubMed Google Scholar
27. Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M (2009) Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Acta Neuropathol 117:35–44
    Article CAS PubMed Google Scholar
28. Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G (2004) Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord 5:208–212
    PubMed Google Scholar
29. Van Deerlin VM, Sleiman PM, Martinez-Lage M et al (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions_._ Nat Genet 42:234–239
    Google Scholar
30. Van Deerlin VM, Leverenz JB, Bekris LM et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409–416
    Article PubMed Google Scholar
31. Xie SX, Baek Y, Grossman M et al (2010) Building an integrated neurodegenerative disease database at an academic health center. Alzheimers Dement (in press)

Download references

Acknowledgments

We thank the patients who contributed samples to this study. We thank Robert Greene and Young Baek for technical assistance. This work was supported by the NIH (AG033101, AG17586, AG10124, AG17586, AG32953, NS44266), as well as a Burroughs Wellcome Fund Career Award for Medical Scientists and the Benaroya Fund (to ACP), and the Koller Family Foundation. VMYL is the John H. Ware, 3rd, Professor of Alzheimer’s Disease Research. JQT is the William Maul Measey-Truman G. Schnabel, Jr., Professor of Geriatric Medicine and Gerontology.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

1. Department of Neurology, University of Pennsylvania School of Medicine, 3 W Gates, 3400 Spruce Street, Philadelphia, PA, 19104, USA
   Ryan Vass, Emily Ashbridge, Murray Grossman, Lauren Elman, Leo McCluskey & Alice S. Chen-Plotkin
2. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
   Felix Geser, Dana Clay-Falcone, Virginia M. Y. Lee, Vivianna M. Van Deerlin & John Q. Trojanowski
3. Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
   Felix Geser, Dana Clay-Falcone, Virginia M. Y. Lee & John Q. Trojanowski
4. Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
   William T. Hu
5. Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
   Virginia M. Y. Lee & John Q. Trojanowski
6. Julia R. Masterman School, Philadelphia, PA, USA
   Emily Ashbridge

Authors

1. Ryan Vass
   You can also search for this author inPubMed Google Scholar
2. Emily Ashbridge
   You can also search for this author inPubMed Google Scholar
3. Felix Geser
   You can also search for this author inPubMed Google Scholar
4. William T. Hu
   You can also search for this author inPubMed Google Scholar
5. Murray Grossman
   You can also search for this author inPubMed Google Scholar
6. Dana Clay-Falcone
   You can also search for this author inPubMed Google Scholar
7. Lauren Elman
   You can also search for this author inPubMed Google Scholar
8. Leo McCluskey
   You can also search for this author inPubMed Google Scholar
9. Virginia M. Y. Lee
   You can also search for this author inPubMed Google Scholar
10. Vivianna M. Van Deerlin
    You can also search for this author inPubMed Google Scholar
11. John Q. Trojanowski
    You can also search for this author inPubMed Google Scholar
12. Alice S. Chen-Plotkin
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toAlice S. Chen-Plotkin.

Additional information

R. Vass and E. Ashbridge contributed equally to this work.

Rights and permissions

About this article

Cite this article

Vass, R., Ashbridge, E., Geser, F. et al. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis.Acta Neuropathol 121, 373–380 (2011). https://doi.org/10.1007/s00401-010-0782-y

Download citation

• Received: 23 September 2010
• Revised: 14 November 2010
• Accepted: 15 November 2010
• Published: 23 November 2010
• Issue Date: March 2011
• DOI: https://doi.org/10.1007/s00401-010-0782-y

Keywords